Wednesday, November 9, 2022

Paxlovid May Reduce Risk of Long Covid in Eligible Patients, Study Finds

https://ift.tt/auRNOvn



The research looked at patients who qualified for the antiviral through age or health conditions. Those who took it shortly after infection were 26 percent less likely to have symptoms 90 days later.



Source link



source https://financetin.com/paxlovid-may-reduce-risk-of-long-covid-in-eligible-patients-study-finds/financetin.com

Related Posts:

  • Studies Detail Syndrome in Kids Linked to COVID Nearly 300 children in 26 states fell ill with a mysterious COVID-related inflammatory condition between March and May, a pair of new studies show. from WebMD Healthhttps://img.webmd.com/dtmcms/live/webmd/consumer_assets/s… Read More
  • Tracking Vaccination Status by Phone Is Now ActiveYou may soon be living in a world where your personal health data — including results from COVID-19 testing and data proving whether or not you've received certain vaccines — must be shared and authenticated before you're abl… Read More
  • The Best New Climbing Gear for 2020Yosemite National Park is now open (with limits; campgrounds remain closed). As a local climber, this means I’m taking day-trips into the nearby park and revisiting my favorite famed routes in the “Center of the Universe,” as… Read More
  • Hidden Funds Lead to Massive Layoffs at Health DepartmentA concerning proportion of scientists — so far 54 in all — have been fired or resigned due to an investigation by the U.S. National Institutes of Health (NIH), which is looking into the researchers’ undisclosed ties to foreig… Read More
  • Majority of People Are Already Resistant to SARS-CoV-2According to research1 conducted in Switzerland, SARS-CoV-2-specific antibodies are only found in the most severe cases — about 1 in 5. That suggests COVID-19 may in fact be five times more prevalent than suspected. It also m… Read More

0 comments:

Post a Comment